Department of Cardiac Surgery and Cardiology, Assistance Publique-Hôpitaux de Paris, Hospital Henri Mondor, University Paris 12 UPEC, Creteil, France.
Cardiac Surgery Department, Saint Joseph Hospital, Marseille, France.
Eur J Cardiothorac Surg. 2019 Dec 1;56(6):1140-1146. doi: 10.1093/ejcts/ezz216.
The transcarotid (TC) approach for transcatheter aortic valve implantation (TAVI) is potentially an optimal alternative to the transfemoral (TF) approach. Our goal was to compare the safety and efficacy of TC- and TF-TAVI.
Patients who underwent TF-TAVI or TC-TAVI in the prospectively collected FRANCE TAVI registry between January 2013 and December 2015 were compared. Propensity score inverse probability weighting methods were employed to minimize the impact of bias related to non-random treatment assignment.
Of the 11 033 patients included in the current study, 10 598 (96%) underwent a TF-TAVI and 435 (4.1%) had a TC-TAVI. Patients in the TC-TAVI access group presented with a higher risk profile but were significantly younger. There were no differences in the perioperative and 2-year mortality rates after adjustment [odds ratio (OR) 1.02, 95% confidence interval (CI) 0.62-1.68; P = 0.99 and hazard ratio 1.03, 95% CI 0.7-1.35; P = 0.83). TC-TAVI was associated with a significant risk of stroke (OR 2.42, 95% CI 2.01-2.92; P < 0.001), ST-elevation myocardial infarction (OR 7.32, 95% CI 3.87-13.87; P < 0.001), infections (OR 2.36, 95% CI 2.04-2.71; P < 0.001), bleeding (OR 2.01, 95% CI 1.76-2.29; P < 0.001), renal failure (OR 2.23, 95% CI 1.90-2.60; P < 0.001) and need for dialysis (OR 2.36, 95% CI 2.01-2.76, P < 0.001). Conversely, TC-TAVI was not confirmed as a risk factor for pacemaker implantation after adjustment (OR 1.05, 95% CI 0.96-1.15; P < 0.28) and was a protective factor for vascular complications (OR 0.37, 95% CI 0.32-0.43; P < 0.001).
TC-TAVI is a safe procedure compared to TF-TAVI, although it holds an increased risk of perioperative complications. It should be considered in case of non-femoral peripheral access as the second access choice, to increase the overall safety of TAVI procedures.
经颈动脉(TC)入路行经导管主动脉瓣置换术(TAVI)可能是经股动脉(TF)入路的一种理想替代方法。我们的目标是比较 TC 和 TF-TAVI 的安全性和疗效。
在 2013 年 1 月至 2015 年 12 月期间前瞻性收集的 FRANCE TAVI 注册中心中,比较了接受 TF-TAVI 或 TC-TAVI 的患者。采用倾向评分逆概率加权法来尽量减少与非随机治疗分配相关的偏倚的影响。
在当前研究中,纳入了 11033 例患者,其中 10598 例(96%)接受 TF-TAVI,435 例(4.1%)接受 TC-TAVI。TC-TAVI 组患者的风险状况更高,但明显更年轻。在调整后,围手术期和 2 年死亡率无差异[比值比(OR)1.02,95%置信区间(CI)0.62-1.68;P=0.99 和风险比 1.03,95%CI 0.7-1.35;P=0.83]。TC-TAVI 与卒中和 ST 段抬高型心肌梗死(OR 2.42,95%CI 2.01-2.92;P<0.001)、感染(OR 2.36,95%CI 2.04-2.71;P<0.001)、出血(OR 2.01,95%CI 1.76-2.29;P<0.001)、肾功能衰竭(OR 2.23,95%CI 1.90-2.60;P<0.001)和需要透析(OR 2.36,95%CI 2.01-2.76,P<0.001)的风险显著增加相关。相反,在调整后,TC-TAVI 未被确认为起搏器植入的危险因素(OR 1.05,95%CI 0.96-1.15;P<0.28),并且是血管并发症的保护因素(OR 0.37,95%CI 0.32-0.43;P<0.001)。
与 TF-TAVI 相比,TC-TAVI 是一种安全的手术方法,尽管它有围手术期并发症的风险增加。如果需要非股动脉外周入路,作为第二种入路选择,应考虑 TC-TAVI,以提高 TAVI 手术的整体安全性。